Chu et al. found an overall increase of plasma CEA in 56% of the 23 patients studied (11), while Guinan et al. found similar (41%) CEA positivity in their 23 patients with renal-cell carcinoma (12). Here, CEACAM5 is linked to renal cell carcinoma.